Nanobodies

2023-02-20 2919

Nanobodies are tiny, recombinantly produced antigen binding VHH fragments, derived from the Alpaca heavy chain IgG antibody (HCAb).Nanobodies have become an essential tool in drug discovery. They are helping scientists design new therapeutics,and develop medicines that could one day replace complex treatment regimens with single, multi-action medicines. Combined with AntibodySystem's large-scale manufacturing capacity, Nanobodies and other cutting-edge technologies are empowering scientists develop the medicines of tomorrow.

Nanobodies come in a variety of formats. They are raised against a fairly diverse range of antigens, and are thus highly versatile tools, capable of being employed in a variety of different situations.The most common uses for a nanobody are experiments that you are likely already familiar with, like immunoprecipitation, or fluorescence microscopy.

When compared to traditional monoclonal or polyclonal antibodies, nanobodies are:Smaller,More consistent,Higher affinity,Easier to use

The VHH domain represents the absolute smallest antibody fragment necessary to specifically bind an antigen with exceptionally high affinity.

Highlight:

Smaller molecular weight:The molecular weight is only 15kDa, which is 1/10 of traditional antibody. The steric hindrance is smaller and easier to approach the target.

Dual tag recognition：8His+Cys-tag;

High coupling efficiency :Cys-tag was designed independently to realize the efficient and High-efficient directional labeling and conjugating

Stronger Specificity:Compared with traditional antibodies, removing the FC tail contributes to less interference signal, lower background as well as higher activity.

Extensive target coverage: 2000 active nanobodies, nearly 1000 targets

Wide applications: Neutralization blocking,Immunoprecipitation,Western blot,Affinity determination,Flow detection,Radioimmunoassay and other related experiments

Excellent mammalian expression system: In contrast to the conventional nanbodies which mostly employ prokaryotic expression system, the whole series of Magic-XtenNano®Nanobody adopts the state-of-art XtenCHO™ mammalian expression system originated from France, can better guarantee correct modification and activity.

Quality control: All the production process are implemented in clean room and endotoxin is at relatively low level, meeting the needs of various experiments.

All products are for research use only